pentoxifylline has been researched along with Cardiomyopathy, Congestive in 9 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "In patients with idiopathic dilated cardiomyopathy, the addition of pentoxifylline to treatment with digoxin, ACE inhibitors, and carvedilol is associated with a significant improvement in symptoms and left ventricular function." | 2.70 | Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study. ( Bergemann, A; Candy, G; Sareli, P; Skudicky, D; Sliwa, K, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 8 (88.89) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sliwa, K | 5 |
| Woodiwiss, A | 2 |
| Candy, G | 4 |
| Badenhorst, D | 1 |
| Libhaber, C | 2 |
| Norton, G | 1 |
| Skudicky, D | 4 |
| Sareli, P | 4 |
| Staudt, A | 1 |
| Landsberger, M | 1 |
| Staudt, Y | 1 |
| Felix, SB | 1 |
| Bahrmann, P | 1 |
| Hengst, UM | 1 |
| Richartz, BM | 1 |
| Figulla, HR | 1 |
| Libhaber, E | 1 |
| Zhanje, F | 1 |
| Motara, R | 1 |
| Essop, R | 1 |
| Wisenbaugh, T | 1 |
| Bergemann, A | 2 |
| Latini, R | 1 |
| Negrusz-Kawecka, M | 1 |
2 reviews available for pentoxifylline and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
[Cytokines--causes, players or bystanders in heart failure].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Cardiomyopathy, Dilated; C | 2002 |
[The role of TNF-alpha in the etiopathogenesis of heart failure].
Topics: Cardiomyopathy, Dilated; Etanercept; Heart Failure; Humans; Immunoglobulin G; Immunologic Factors; P | 2002 |
5 trials available for pentoxifylline and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
Effects of pentoxifylline on cytokine profiles and left ventricular performance in patients with decompensated congestive heart failure secondary to idiopathic dilated cardiomyopathy.
Topics: Adjuvants, Immunologic; Cardiomyopathy, Dilated; Cytokines; Double-Blind Method; Drug Administration | 2002 |
Pentoxifylline in ischemic, hypertensive and idiopathic-dilated cardiomyopathy: effects on left-ventricular function, inflammatory cytokines and symptoms.
Topics: Cardiomyopathy, Dilated; Double-Blind Method; Echocardiography; Female; Humans; Interleukin-6; Male; | 2004 |
Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy.
Topics: Cardiomyopathy, Dilated; Double-Blind Method; Female; Gated Blood-Pool Imaging; Humans; Male; Middle | 1998 |
Reduction in Fas/APO-1 plasma concentrations correlates with improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy treated with pentoxifylline.
Topics: Adult; Apoptosis; Biomarkers; Cardiomyopathy, Dilated; Case-Control Studies; Double-Blind Method; fa | 2000 |
Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study.
Topics: Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Digoxin; | 2001 |
2 other studies available for pentoxifylline and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
C-reactive protein predicts response to pentoxifylline in patients with idiopathic dilated cardiomyopathy.
Topics: C-Reactive Protein; Cardiomyopathy, Dilated; fas Receptor; Humans; Pentoxifylline; Predictive Value | 2004 |
[Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol. Results of a randomised study].
Topics: Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Humans; P | 2001 |